CDK4 and neoplasm: With the knowledge of the numerous effects of CDK4/6i therapy on tumor cells, Tregs, cytotoxic T cells, and even stem and progenitor cells, it is reasonable to assume that the pretreatment status of the tumor immunity may have predictive value.